Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:

Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Scarlet Fu, Isabelle Lee, Carol Massar and Joe Deaux

- Amylyx Pharmaceuticals (AMLX) shares climb as much as 43%, the most intraday since September 2022, after the drug developer said a late-stage trial of its experimental drug met its primary endpoint as a treatment for patients who experience dangerously low blood sugar levels following bariatric surgery. Stifel views the results as a “best-case scenario.”

- Targa Resources (TRGP) shares rose 6.9% after the energy company signed new 20-year, fee-based integrated midstream agreements with ExxonMobil subsidiaries covering gathering, processing, NGL transportation, and fractionation across the Permian Basin through 2046.

- Klarna (KLAR) shares are down more than 20% after the payments company reported full year revenue and gross merchandise value guidance that missed expectations. Active consumers for the second quarter also missed expectations.

Today's biggest winners and losers in the stock market. On this episode of Stock Movers: Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Scarlet Fu, Isabelle Lee, Carol Massar and Joe Deaux - Amylyx Pharmaceuticals (AMLX) shares climb as much as 43%, the most intraday since September 2022, after the drug developer said a late-stage trial of its experimental drug met its primary endpoint as a treatment for patients who experience dangerously low blood sugar levels following bariatric surgery. Stifel views the results as a &ldquo;best-case scenario.&rdquo; - Targa Resources (TRGP) shares rose 6.9% after the energy company signed new 20-year, fee-based integrated midstream agreements with ExxonMobil subsidiaries covering gathering, processing, NGL transportation, and fractionation across the Permian Basin through 2046. - Klarna (KLAR) shares are down more than 20% after the payments company reported full year revenue and gross merchandise value guidance that missed expectations. Active consumers for the second quarter also missed expectations.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. 

Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Listen for five-minute conversations on today's biggest winners and losers in the stock market.&nbsp;
Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Listen for news on today's biggest winners and losers in the stock market.

Stock Movers

Closing Bell: Amylyx Pharmaceuticals Climbs, Targa Rises, Klarna Plunges

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/00a67a5d-2324-4f0e-9b2d-b4aa014c1051/transcript